相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial
Deanna Kerrigan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Long-acting drugs and formulations for the treatment and prevention of HIV infection
Charles Flexner et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment
Andrew Mulato et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Novel Antiretroviral Agents
Mary C. Cambou et al.
CURRENT HIV/AIDS REPORTS (2020)
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Edgar T. Overton et al.
LANCET (2020)
Adherence to HIV treatment regimens: systematic literature review and meta-analysis
Frederick Altice et al.
PATIENT PREFERENCE AND ADHERENCE (2019)